Inspire Medical Systems, Inc.
$1.63B- Market cap
- $1.82B
- Debt
- +$112.36M
- Cash
- −$308.27M
Capital structure 94% equity / 6% debt · EV / Revenue 1.78x · EV / EBITDA 24.73x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 ·
Decision snapshot: INSP stock price at discount vs SNA $63.08 current versus $97.60 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SNA's multiple
Implied fair value · at INSP's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INSP FY 2025 (ended Dec 31, 2025) · SNA FY 2026 (ended Jan 3, 2026). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 1.78x · EV / EBITDA 24.73x
Capital structure 94% equity / 6% debt · EV / Revenue 3.76x · EV / EBITDA 13.24x
SNA carries the larger enterprise value at $19.41B against $1.63B; INSP trades on the lower EV / Revenue multiple (1.78x vs 3.76x); SNA on the lower EV / EBITDA (13.24x vs 24.73x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Inspire Medical Systems, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Snap-on Inc · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.14x
0.21x
Net debt / EBITDA
Leverage against operating earnings
-2.98x
-0.28x
Cash and equivalents
Liquid reserves on the balance sheet
$308.27M
$1.62B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BOSTON SCIENTIFIC CORP
INSP vs BSX
Medtronic plc
INSP vs MDT
ABBOTT LABORATORIES
INSP vs ABT
JOHNSON & JOHNSON
INSP vs JNJ
LivaNova PLC
INSP vs LIVN
Trane Technologies plc
INSP vs TT
IDEX CORP /DE/
INSP vs IEX
SPX Technologies, Inc.
INSP vs SPXC
Xylem Inc.
INSP vs XYL
DOVER Corp
INSP vs DOV
Ingersoll Rand Inc.
INSP vs IR
$112.36M
$1.22B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.